» Articles » PMID: 30472983

Segmental Ureterectomy Can Be Performed Safely in Patients with Urothelial Carcinoma of Distal Ureter

Overview
Specialty Urology
Date 2018 Nov 27
PMID 30472983
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: We aimed to compare oncological outcomes by surgery type (segmental ureterectomy [SU] vs. radical nephroureterectomy [RNU]) in a large cohort of patients with upper tract urothelial carcinoma (UTUC) of the distal ureter.

Methods: We performed a retrospective analysis of 219 patients with UTUC of the distal ureter among 931 patients with UTUC who underwent SU and RNU. Clinicopathological outcomes were evaluated. Cancer-specific survival (CSS), overall survival (OS), local recurrence-free survival (RFS), intravesical recurrence-free survival (IVRFS), contralateral recurrence-free survival, and distal metastasis-free survival were assessed by the Kaplan-Meier method and Cox regression, estimating hazard ratios (HR) and 95% confidence intervals (CIs).

Results: A total of 179 (81.7%) patients underwent RNU and 40 (18.3%) underwent SU: 85 males (47.5%) with RNU and 17 (42.5%) with SU (p=0.568). The median age with RNU and SU was 71 years (range 31-86) and 70 years (range 46-90), respectively (p=0.499). The T stage of the two groups did not differ (p=0.122), nor did mean tumour length (3.35±2.62 vs. 3.25±2.14; p=0.953), grade (p=0.075), tumour necrosis (p=0.634), or followup time (months) (58.1±8.1 vs. 63.7±3.4; p=0.462). The two groups did not differ in CSS (p=0.358) or OS (p=0.206), and surgery type did not predict CSS (HR 0.862; 95% CI 0.469-1.585; p=0.633) or OS (HR 0.764; 95% CI 0.419-1.392; p=0.379). Local RFS was higher with RNU than SU (96.2% vs. 86.0%; p=0.02), but the groups did not differ in IVRFS (p=0.661), contralateral RFS (p=0.183), or distant metastasis-free survival (p=0.078). On multivariate analysis, SU was associated with local RFS (HR 5.069; 95% CI 1.029-24.968; p=0.046) and distant metastasis-free survival (HR 6.497; 95% CI 1.196-35.283; p=0.03). Local RFS was lower with SU than RNU for patients with pT3-4 stage (p=0.006).

Conclusions: Long-term oncological outcomes were equivalent with SU and RNU in patients with UTUC of the distal ureter. SU affected local recurrence survival, especially with advanced tumour stage, and distant metastasis survival.

Citing Articles

Navigating the Aftermath: A Comprehensive Scoping Review on Follow-up Strategies After Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma.

Schuil H, Figaroa O, Hendriks N, Schout B, Beerlage H, van Jamaludin F Eur Urol Open Sci. 2024; 66:82-92.

PMID: 39050911 PMC: 11268123. DOI: 10.1016/j.euros.2024.06.005.


Right-sided ureteral hemangiosarcoma in a paraplegic dog.

Maia S, Manochio M, Soares L, Andrade Y, Alvarenga A, Crivellenti L BMC Vet Res. 2024; 20(1):271.

PMID: 38909227 PMC: 11193175. DOI: 10.1186/s12917-024-04114-8.


Clinicopathological characteristics, surgical treatments, and oncological outcomes of localized primary unifocal urothelial carcinoma involving the ureterovesical junction.

Zhai H, Wang Y, Chen Z, Wang Z, Xing J, Zhu X Int Urol Nephrol. 2023; 56(3):941-955.

PMID: 37847324 DOI: 10.1007/s11255-023-03838-0.


Modern Kidney-Sparing Management of Upper Tract Urothelial Carcinoma.

Ghoreifi A, Sari Motlagh R, Fuchs G Cancers (Basel). 2023; 15(18).

PMID: 37760465 PMC: 10526335. DOI: 10.3390/cancers15184495.


Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee.

Masson-Lecomte A, Vaillant V, Roumiguie M, Levy S, Pradere B, Peyromaure M Cancers (Basel). 2022; 14(21).

PMID: 36358870 PMC: 9656759. DOI: 10.3390/cancers14215452.

References
1.
Munoz J, Ellison L . Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000; 164(5):1523-5. View

2.
Pohar K, Sheinfeld J . When is partial ureterectomy acceptable for transitional-cell carcinoma of the ureter?. J Endourol. 2001; 15(4):405-8; discussion 409. DOI: 10.1089/089277901300189439. View

3.
Oosterlinck W, Solsona E, van der Meijden A, Sylvester R, Bohle A, Rintala E . EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol. 2004; 46(2):147-54. DOI: 10.1016/j.eururo.2004.04.011. View

4.
Roupret M, Harmon J, Sanderson K, Barret E, Cathelineau X, Vallancien G . Laparoscopic distal ureterectomy and anastomosis for management of low-risk upper urinary tract transitional cell carcinoma: preliminary results. BJU Int. 2007; 99(3):623-7. DOI: 10.1111/j.1464-410X.2006.06688.x. View

5.
Jeldres C, Lughezzani G, Sun M, Isbarn H, Shariat S, Budaus L . Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J Urol. 2010; 183(4):1324-9. DOI: 10.1016/j.juro.2009.12.018. View